InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.49
(
0.55%
)
Bitcoin
62,519.07
(
-1.01%
)
Post# of 4972695
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BlazingStocks

Send PM Follow Ignore
Followers 167
Posts 36076
Boards Moderated 7
Alias Born 10/20/2019

BlazingStocks

Member Level

Re: Natural Trader post# 4933244

Wednesday, 06/07/2023 11:10:51 AM

Wednesday, June 07, 2023 11:10:51 AM

Post# of 4972695
$NBIO - "The presentation displayed our Phase I data, which included our safety data at various dose cohorts and early outcomes data, was well received and viewed by interested parties at the conference. In summary, it showed the drug to be very safe at 5 ascending dose cohorts and definitive bioactivity in several patients," stated Dr. Mini Gill who presented for the Company.
https://finance.yahoo.com/news/nascent-biotech-phase-clinical-data-120000403.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up